FdaApplication
NDA 020741
Identifiers
- fda_app_no: NDA020741
Properties
| Property | Value |
|---|---|
| applicant_name | GEMINI LABORATORIES LLC |
| application_type | NDA |
| approval_date | 1997-12-22 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PRANDIN | REPAGLINIDE | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| PRANDIN | REPAGLINIDE | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| PRANDIN | REPAGLINIDE | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
3 products